NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/30/2026
Back to search
Official data from USPTO
RADMAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RADMAB
ST13
US500000079288877Class
5, 10, 42
Filing
79288877
Registration
6253802
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/30/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
03/02/2020
Registration date
01/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2021
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
STRUCK, ROBERT J
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Telix Pharmaceuticals Limited
Representatives
Andrew S. Ehard Merchant & Gould P.C.
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for pharmaceutical purposesdiagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imagingdiagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imagingdiagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vialsneedleless drug delivery devicesswabable vial adaptors and medical syringes; all of the foregoing containing monoclonal antibodies
Class 10
Medical apparatusinfusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposesdrug delivery devices for diagnostic radiopharmaceuticals; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparationsdrug delivery devices sold empty being syringesinfusion sets and catheters
Class 42
Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistrybiotechnology and clinical trials; scientific consultancyconsulting services in the fields of biotechnologypharmaceutical research and developmentgenetic science all of the aforementioned in relation to radiopharmaceuticals and cancer
Publications
History of USPTO decisions and trademark events.
26 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/26/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/14/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/30/2021
FIMP
FINAL DISPOSITION PROCESSED
04/30/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2020
PUBO
PUBLISHED FOR OPPOSITION
11/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2020
RFNT
REFUSAL PROCESSED BY IB
09/27/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/21/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2020
RFRR
REFUSAL PROCESSED BY MPU
08/27/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/24/2020
CNRT
NON-FINAL ACTION WRITTEN
07/23/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/21/2020
DOCK
ASSIGNED TO EXAMINER
07/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/15/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/02/2020
Continuous trademark protection
Get notified about every new filing that threatens RADMAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.